{"disease":{"id":"aml-according-to-who-2016-classification-except-acute-promyelocytic-leukemia-and-refractory-to-induction-therapy-or-relapsed-after-first-line-treatment.md","name":"aml according to who 2016 classification except acute promyelocytic leukemia and refractory to induction therapy or relapsed after first line treatment.md"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[],"total":0},"guidelines":[],"source":"Drug Landscape verified database"}